https://dom-pubs.pericles-prod.literatumonline.com/doi/10.1111/dom.16647

4 Likes

It depends a lot on how the study is done. Obese people might benefit but others do not: No association between metformin initiation and incident dementia in older adults newly diagnosed with diabetes 2023

And even in obese people, GLP-1RAs do better than metformin:

4 Likes

Thanks

The other difference above might be that Metformin can help prevent (as in the study Aging Doc) posted vs cannot reverse (or slow) AD once it has gotten going?

The paper concludes “The utility of metformin to prevent dementia was not supported.” so I don’t think metformin can prevent dementia. And if it does it’s probably a weak effect, certainly weaker than SGLT2i and GLP-1RAs (and their combination?).

1 Like

https://x.com/bryan_johnson/status/1953540110374645892

3 Likes

I found it interesting that he had energy markers, what are these?

image

4 Likes

To be honest it is typical for him. He provides values, but does not explain what the units are. (Obviously percentages don’t have units, but they are percentages of something).

4 Likes

Kobe University endocrinologist Ogawa Wataru says, "It is known that diabetes patients experience changes in the blood levels of metals such as copper, iron and zinc.

"In addition, chemical studies found that metformin has the ability to bind certain metals, such as copper, and recent studies showed that it is this binding ability that might be responsible for some of the drug’s beneficial effects. So, we wanted to know whether metformin actually affects blood metal levels in humans, which had not been clarified.

In the journal BMJ Open Diabetes Research & Care , the Kobe University team has published the first clinical evidence of altered blood metal levels in patients taking metformin. They showed that drug-taking patients have significantly lower copper and iron levels and heightened zinc levels.

Association of metformin treatment with changes in metal dynamics in individuals with type 2 diabetes,

BMJ Open Diabetes Research & Care (2025).

DOI: 10.1136/bmjdrc-2025-005255

5 Likes

Metformin may weaken cardiovascular, insulin benefits of exercise

3 Likes

Metformin as a longevity drug

Renewed hope from primate and human data

3 Likes

An interesting idea to cycle metformin

Metformin is one of the strongest AMPK activators - but only when used in the right context.

If you take it in a pulsed way and pair it with the right dietary signals (low glucose/low insulin window, mild caloric deficit, fasted zone 1/2, etc.), it can really show its value, amplifying AMPK cascade.

What many people expect is a “magic pill” you take every day and it fixes everything. But biology doesn’t work like that - continuous daily dosing can blunt the metabolic signal and even interfere with adaptations.

5 Likes
6 Likes

This seems similar to the research that came out years ago. It’s why I avoid it generally…

3 Likes

I also avoid it because it’s hard on kidneys - otherwise I would take it.

It appears that Metformin crosses the BBB and directly affects the brain.

After 60 Years, Diabetes Drug Found to Unexpectedly Affect The Brain : ScienceAlert

1 Like